• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY VISIAN ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY VISIAN ICL (IMPLANTABLE COLLAMER LENS); INTRAOCULAR LENS Back to Search Results
Model Number MICL13.7
Device Problems Inadequacy of Device Shape and/or Size (1583); Appropriate Term/Code Not Available (3191)
Patient Problems Pulmonary Regurgitation (2023); No Code Available (3191)
Event Type  Injury  
Event Description
The reporter stated the surgeon implanted a 13.7mm micl13.7 implantable collamer lens in the patient's right eye (od) on (b)(6) 2014.The lens was explanted on (b)(6) 2014 due to excessive vaulting.Subsequently, the patient experienced pupillary block and elevated intraocular pressure (iop).The reporter stated for the first two days post-op, the lens had a mild vault and the surgeon enlarged the peripheral iridectomy, but with no success.The lens was exchanged for a shorter lens.The surgeon felt the event was not due to the icl, it was more of an issue with poor sizing.The reporter stated the lens was discarded.
 
Manufacturer Narrative
(b)(4).Evaluation method: work order search.Results: a lens work order search was performed and no similar complaints were found within the work order.Conclusions: no conclusion can be drawn.Based on the complaint history and work order search, a specific root cause of the event could not be determined.(b)(4).Lens was discarded.
 
Manufacturer Narrative
Method: medical review.Results: per medical review - reportedly, by a surgeon, the icl (13.7 mm long) was explanted/exchanged, two weeks postoperatively, for a different length icl (13.2 mm) to address excessive vaulting and subsequent pupillary block and elevated iop.No reported postoperative sequelae.Before lens exchange the surgeon enlarged pis but the issue was not resolved.According to the surgeon the reported event was attributed to the pre-operative procedure (measurements).Conclusions: based on the complaint history, work order search and the medical review, a probable cause of the event has been attributed to the pre-operative procedure (measurements).(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VISIAN ICL (IMPLANTABLE COLLAMER LENS)
Type of Device
INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-25 60
SZ  CH-2560
Manufacturer (Section G)
STAAR SURGICAL COMPANY
haupstrasse 104
nidau, CH-2 560
SZ   CH-2560
Manufacturer Contact
althea watson
1911 walker avenue
monrovia, CA 91016
6263037902
MDR Report Key3907603
MDR Text Key4586944
Report Number2023826-2014-00489
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P030016
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/06/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date10/31/2014
Device Model NumberMICL13.7
Other Device ID NumberDIOPTER -12.0
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/22/2014
Initial Date FDA Received07/01/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/16/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/16/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age24 YR
-
-